Precision pulmonary medicine: Penn engineers target lung disease with lipid nanoparticles
Penn Engineers have developed a new means of targeting the lungs with lipid nanoparticles (LNPs), the miniscule capsules used by the Moderna and Pfizer-BioNTech COVID-19...